National Breast Cancer Audit: Ductal carcinoma in situ management in Australia and New Zealand

ANZ Journal of Surgery

Volumn 77, Issue 1-2, 2007, Pages 64-68

  Cuncins Hearn, Astrid ^a   Boult, Margaret ^a   Babidge, Wendy ^a,b   Zorbas, Helen ^c   Villanueva, Elmer ^c   Evans, Alison ^c   Oliver, David ^e   Kollias, James ^a   Reeve, Tom ^d   Maddern, Guy ^a,b  

^a ROYAL AUSTRALASIAN COLLEGE OF SURGEONS   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c National Breast Cancer Centre   (Australia)

^d Australian Cancer Society   (Australia)

^e ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

Breast conserving surgery; Breast neoplasm; Clinical practice pattern; Intraductal carcinoma; Segmental mastectomy

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; AUSTRALIA; BREAST CANCER; BREAST DUCT; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; DATA ANALYSIS; DATA BASE; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL AUDIT; NEW ZEALAND; PREDICTION; PRESCRIPTION; TUMOR BIOPSY;

ANTINEOPLASTIC AGENTS, HORMONAL; AUSTRALIA; AXILLA; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; GUIDELINE ADHERENCE; HUMANS; LYMPH NODE EXCISION; MAMMOGRAPHY; MASTECTOMY, SEGMENTAL; MEDICAL AUDIT; MIDDLE AGED; NEW ZEALAND; RADIOTHERAPY, ADJUVANT; TAMOXIFEN;

EID: 33846520559     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2006.03979.x     Document Type: Article

References (25)

1. Leonard GD, Swain SM. Ductal carcinoma in situ: complexities and challenges. J. Natl Cancer Inst. 2004; 96: 906-20.
2. Shugg D, White VM, Kitchen PRB, Pruden M, Collins JP, Hill DJ. Surgical management of ductal carcinoma in situ in Australia in 1995. ANZ J. Surg. 2002; 72: 708-15.
3. Ductal Carcinoma In Situ and Lobular Carcinoma In Situ and Atypical Hyperplasia Working Group. The Clinical Management of Ductal Carcinoma in situ, Lobular Carcinoma In Situ and Atypical Hyperplasia of the Breast, 1st edn. Sydney: National Breast Cancer Centre, 2003.
4. House of Representatives Standing Committee on Community Affairs. Report on the Management and Treatment of Breast Cancer in Australia. Canberra, Australia: Australian Government Publication Service, 1995.
5. Goldstein H. Multi-level statistical models. Kendall's Library of Statistics, Vol. 3. London: Arnold Publishing, 2003.
6. Frost C, Kenward MG, Fox NC. The analysis of repeated 'direct' measures of change illustrated with an application in longitudinal imaging. Stat. Med. 2004; 23: 3275-86.
7. Royall RM. Model robust confidence intervals using maximum likelihood estimators. Int. Statist. Rev. 1986; 54: 221-6.
8. Larsen K, Petersen JH, Budtz-Jorgensen E, Endhal L. Interpreting parameters in the logistic regression model with random effects. Biometrics 2000; 56: 909-14.
9. Sakorafas GH, Farley DR. Optimal management of ductal carcinoma in situ of the breast. Surg. Oncol. 2003; 12: 221-40.
10. Sakorafas GH, Tsiotou AG. Selection criteria for breast conservation in breast cancer. Eur. J. Surg. 2000; 166: 835-46.
11. Hwang ES, Esserman LJ. Management of ductal carcinoma in situ. Surg. Clin. North Am. 1999: 79: 1007-30.
12. Baxter NN, Virnig BA, Durham SB, Tuttle TM. Trends in the treatment of ductal carcinoma in situ of the breast. J. Natl Cancer Inst. 2004; 96: 443-8.
13. Recht A, van Dongen JA, Fentiman IS, Holland R, Peterse JL. Third meeting of the DCIS working party of the EORTC, S Giorgio, Venice, 28 February 1994. Eur. J. Cancer 1994; 30A: 1895-900.
14. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. Cancer 1999; 85: 616-28.
15. Cataliotti L, Distante V, Ciatto S. Intraductal breast cancer: review of 183 consecutive cases. Eur. J. Cancer 1992; 28A: 917-20.
16. Cutuli B, Tessier E, Piat JM. Radical surgery and conservative treatment of ductal carcinoma in situ of the breast. Eur. J. Cancer 1992; 28: 649-54.
17. Fisher ER, Sass R, Fisher B, Wickerham L, Paik SM. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): I. Intraductal carcinoma (DCIS). Cancer 1986; 57: 197-208.
18. Cuzick J. Treatment of DCIS: results from clinical trials. J. Surg. Oncol. 2003; 12: 213-19.
19. Fisher B, Lord S, Mamounas E. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin. Oncol. 2001; 28: 400-418.
20. Fisher ER, Constantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17; Intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75: 1310-19.
21. Fisher B, Dignam J, Wolmark N et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999: 353: 1993-2000.
22. Silverstein M. The treatment controversy: do all conservatively patients require post excisional radiation therapy? J. Am. Coll. Surg. 2001; 192: 199-201.
23. Jackman RJ, Burbank F, Parker SH, Evans WP 3rd, Lechner MC, Richardson TR. Stereotactic breast biopsy of non-palpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218: 497-502.
24. Cuzick J. Aromatase inhibitors in prevention: data from the ATAC (Arimidex, Tamoxifen Alone and Combination) Trial and Design of IBIS-II (Second International Breast Cancer Intervention Study). Recent Results in Cancer Res. 2003; 163: 96-103.
25. Mokbel K. Towards optimal management of ductal carcinoma in situ of the breast. Eur. J. Surg. Oncol. 2003; 29: 191-7.